Literature DB >> 18678670

Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components.

Karen L Wozniak1, Stuart M Levitz.   

Abstract

Cryptococcus neoformans is an opportunistic fungal pathogen that primarily causes disease in immunocompromised individuals. Dendritic cells (DCs) can phagocytose C. neoformans, present cryptococcal antigen, and kill C. neoformans. However, early events following C. neoformans phagocytosis by DCs are not well defined. We hypothesized that C. neoformans traffics to the endosome and the lysosome following phagocytosis by DCs and is eventually killed in the lysosome. Murine bone marrow-derived DCs (BMDCs) or human monocyte-derived DCs (HDCs) were incubated with live, encapsulated C. neoformans yeast cells and opsonizing antibody. Following incubation, DCs were intracellularly stained with antibodies against EEA1 (endosome) and LAMP-1 (late endosome/lysosome). As assessed by confocal microscopy, C. neoformans trafficked to endosomal compartments of DCs within 10 min and to lysosomal compartments within 30 min postincubation. For HDCs, the studies were repeated using complement-sufficient autologous plasma for the opsonization of C. neoformans. These data showed results similar to those for antibody opsonization, with C. neoformans localized to endosomes within 20 min and to lysosomes within 60 min postincubation. Additionally, the results of live real-time imaging studies demonstrated that C. neoformans entered lysosomal compartments within 20 min following the initiation of phagocytosis. The results of scanning and transmission electron microscopy demonstrated conventional zipper phagocytosis of C. neoformans by DCs. Finally, lysosomal extracts were purified from BMDCs and incubated with C. neoformans to determine their potential to kill C. neoformans. The extracts killed C. neoformans in a dose-dependent manner. This study shows that C. neoformans enters into endosomal and lysosomal pathways following DC phagocytosis and can be killed by lysosomal components.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18678670      PMCID: PMC2546838          DOI: 10.1128/IAI.00660-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Role of adaptor complex AP-3 in targeting wild-type and mutated CD63 to lysosomes.

Authors:  Brian A Rous; Barbara J Reaves; Gudrun Ihrke; John A G Briggs; Sally R Gray; David J Stephens; George Banting; J Paul Luzio
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

2.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

3.  In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Jatin M Vyas; Stuart M Levitz
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells.

Authors:  Nicole van der Wel; David Hava; Diane Houben; Donna Fluitsma; Maaike van Zon; Jason Pierson; Michael Brenner; Peter J Peters
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

Review 5.  Prospects for development of vaccines against fungal diseases.

Authors:  Jennifer M Dan; Stuart M Levitz
Journal:  Drug Resist Updat       Date:  2006-07-03       Impact factor: 18.500

6.  Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.

Authors:  C Spiropulu; R A Eppard; E Otteson; T R Kozel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

7.  Biogenesis of Leishmania major-harboring vacuoles in murine dendritic cells.

Authors:  Ulrich Körner; Veronika Fuss; Jutta Steigerwald; Heidrun Moll
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

Review 8.  Towards a vaccine for Cryptococcus neoformans: principles and caveats.

Authors:  Kausik Datta; Liise-anne Pirofski
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

9.  Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages.

Authors:  Mauricio Alvarez; Arturo Casadevall
Journal:  Curr Biol       Date:  2006-11-07       Impact factor: 10.834

10.  Interaction of Salmonella enterica serotype Typhimurium with dendritic cells is defined by targeting to compartments lacking lysosomal membrane glycoproteins.

Authors:  F García-Del Portillo; H Jungnitz; M Rohde; C A Guzmán
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

View more
  40 in total

1.  Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.

Authors:  Sarah E Hardison; Karen L Wozniak; Jay K Kolls; Floyd L Wormley
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Sarika Agarwal; Sanjay Ram; Peter A Rice; Charles A Specht; Stuart M Levitz
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

3.  Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans.

Authors:  John J Osterholzer; Jami E Milam; Gwo-Hsiao Chen; Galen B Toews; Gary B Huffnagle; Michal A Olszewski
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

4.  Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome.

Authors:  David R Boulware; Shulamith C Bonham; David B Meya; Darin L Wiesner; Gregory S Park; Andrew Kambugu; Edward N Janoff; Paul R Bohjanen
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

5.  Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence.

Authors:  Michael J Davis; Alison J Eastman; Yafeng Qiu; Brian Gregorka; Thomas R Kozel; John J Osterholzer; Jeffrey L Curtis; Joel A Swanson; Michal A Olszewski
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

Review 6.  Innate host defenses against Cryptococcus neoformans.

Authors:  Camaron Hole; Floyd L Wormley
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

7.  Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome(IRIS): Pathogenesis and Its Clinical Implications.

Authors:  Darin L Wiesner; David R Boulware
Journal:  Curr Fungal Infect Rep       Date:  2011-12-01

8.  Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Charles A Specht; Stuart M Levitz
Journal:  MBio       Date:  2010-07-20       Impact factor: 7.867

9.  Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Jennifer P Wang; Charles A Specht; Stuart M Levitz
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

Review 10.  Role of dendritic cell-pathogen interactions in the immune response to pulmonary cryptococcal infection.

Authors:  Alison J Eastman; John J Osterholzer; Michal A Olszewski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.